Scorpion venom stings cancer

Article

While the sting of most scorpions is nonlethal to humans, it's not usually considered health-enhancing either. But the venom could actually prove lifesaving.

While the sting of most scorpions is nonlethal to humans, it's not usually considered health-enhancing either. But the venom could actually prove lifesaving.

Dr. James M. Olson and colleagues at the Fred Hutchinson Cancer Research Center in Seattle attached the peptide chlorotoxin to Cy5.5, a fluorescent molecule that emits near-infrared light. Chlorotoxin, a component of scorpion venom, preferentially binds to cancer cells (Cancer Res 2007;67:6882-6888).

The probe lit up malignant gliomas, medulloblastomas, prostate cancer, intestinal cancer, and sarcomas. Brain tumors as small as 1 mm in diameter and as few as 200 metastatic prostate cancer cells were visualized.

The unique contrast agent shows promise for imaging melanoma and skin, esophageal, cervical, lung, and colon cancers. It binds to cancer cells within minutes after injection, but its signal can be detected for 14 days. Iron oxide-based nanoparticles coated with chlorotoxin imaging are being developed for use with MR.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.